Patrick D Walsh, Director, on May 11, 2026, sold 13,973 shares in Ani Pharmaceuticals (ANIP) for $1,127,120. Following the Form 4 filing with the SEC, Walsh has control over a total of 38,432 common shares of the company, with 38,432 shares held directly.
SEC Filing:
Brady Patrick Priest, Chief Executive Officer of Clover Care Services, on May 13, 2026, sold 98,039 shares in Clover Health Investments (CLOV) for $345,097. Following the Form 4 filing with the SEC, Priest has control over a total of 2,040,222 Class A common shares of the company, with 2,040,222 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1801170/000193819726000011/xslF345X05/wk-form4_1778723260.xml
David Malcom Rodman, Chief Medical Officer, on May 11, 2026, sold 22,575 shares in Mineralys Therapeutics (MLYS) for $652,638. Following the Form 4 filing with the SEC, Rodman has control over a total of 63,443 common shares of the company, with 63,443 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1933414/000167265926000027/xslF345X05/wk-form4_1778722925.xml
Anthony Tan Ping Yeow, Director, Chief Executive Officer, on May 11, 2026, sold 400,000 shares in Grab Holdings (GRAB) for $1,469,000. Following the Form 4 filing with the SEC, Yeow has control over a total of 25,193 Class A ordinary shares of the company, with 25,193 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1855612/000185561226000082/xslF345X05/wk-form4_1778722597.xml